Loss of muscle mass in women with premature ovarian insufficiency as compared with healthy controls
- PMID: 36696635
- DOI: 10.1097/GME.0000000000002120
Loss of muscle mass in women with premature ovarian insufficiency as compared with healthy controls
Abstract
Objective: Menopausal transition has been known to be associated with the loss of muscle mass. However, muscle health in women with premature menopause, that is, premature ovarian insufficiency (POI), remains unclear. We aimed to investigate and compare muscle mass parameters and the prevalence of low muscle mass between patients with spontaneous POI and healthy controls.
Methods: In this cross-sectional study, 59 women with spontaneous POI and 57 premenopausal controls with normal ovarian function were enrolled at the Women's Hospital, Zhejiang University School of Medicine (Hangzhou, China) from June 17, 2020, to August 20, 2021. Muscle mass parameters were measured by dual-energy x-ray absorptiometry, and low muscle mass was diagnosed using the Asian Working Group for Sarcopenia criteria. In addition, participants provided their sociodemographic data, menstrual and reproductive history, lifestyle factors, and medical history. Multivariate linear regression analysis was conducted.
Results: Muscle mass parameters, including appendicular skeletal muscle mass (ASM), ASM/height2, ASM/weight, ASM/body mass index, total skeletal muscle mass (TSM), and TSM/weight, were significantly lower in women with POI as compared with healthy controls (ASM: 14.62 ± 2.08 vs 15.97 ± 1.78, P < 0.001; ASM/height2: 5.71 ± 0.64 vs 6.15 ± 0.62, P < 0.001; ASM/weight: 0.27 [0.25, 0.28] vs 0.28 [0.27, 0.29], P = 0.002; ASM/BMI: 0.68 ± 0.07 vs 0.73 ± 0.06, P = 0.001; TSM: 33.85 ± 4.08 vs 36.43 ± 3.56, P < 0.001; TSM/weight: 0.63 [0.59, 0.65] vs 0.64 [0.61, 0.67], P = 0.02). The prevalence of low muscle mass in POI patients was significantly higher than that in controls (32.20% vs 8.77%, χ2 = 9.70, P = 0.002). Furthermore, multivariate linear regression analyses demonstrated that POI status was an independent risk factor for ASM (β = -1.13; 95% CI, -1.62 to -0.65), ASM/height2 (-0.35, -0.47 to -0.22), ASM/weight (-0.01, -0.02 to -0.009), ASM/BMI (-0.05, -0.07 to -0.02), TSM (-2.16, -3.14 to -1.17), and TSM/weight (-0.03, -0.04 to -0.02).
Conclusions: Women with POI exhibit significant loss of muscle mass as compared with healthy controls. Early diagnosis and long-term health management in POI patients are important.
Copyright © 2022 by The North American Menopause Society.
Conflict of interest statement
Financial disclosure/conflicts of interest: None reported.
Comment in
-
Sarcopenia and menopause.Menopause. 2023 Feb 1;30(2):119-120. doi: 10.1097/GME.0000000000002140. Epub 2022 Dec 28. Menopause. 2023. PMID: 36574637 No abstract available.
Similar articles
-
Cardiovascular Risk in Women With Premature Ovarian Insufficiency Compared to Premenopausal Women at Middle Age.J Clin Endocrinol Metab. 2016 Sep;101(9):3306-15. doi: 10.1210/jc.2016-1141. Epub 2016 Jun 14. J Clin Endocrinol Metab. 2016. PMID: 27300572
-
Association of the gut microbiota and fecal short-chain fatty acids with skeletal muscle mass and strength in children.FASEB J. 2022 Jan;36(1):e22109. doi: 10.1096/fj.202002697RRR. FASEB J. 2022. PMID: 34941012 Clinical Trial.
-
Type 2 diabetes is associated with low muscle mass in older adults.Geriatr Gerontol Int. 2014 Feb;14 Suppl 1:115-21. doi: 10.1111/ggi.12189. Geriatr Gerontol Int. 2014. PMID: 24450569
-
The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis.Climacteric. 2023 Apr;26(2):95-102. doi: 10.1080/13697137.2022.2153033. Epub 2022 Dec 15. Climacteric. 2023. PMID: 36519275
-
Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis.Eur J Endocrinol. 2019 Jan 1;180(1):41-50. doi: 10.1530/EJE-18-0602. Eur J Endocrinol. 2019. PMID: 30400047
Cited by
-
Association between serum uric acid, hyperuricemia and low muscle mass in middle-aged and elderly adults: A national health and nutrition examination study.PLoS One. 2025 Jan 7;20(1):e0312235. doi: 10.1371/journal.pone.0312235. eCollection 2025. PLoS One. 2025. PMID: 39775063 Free PMC article.
-
Impaired Muscle Parameters in Individuals With Premature Ovarian Insufficiency: A Pilot Study.J Endocr Soc. 2024 Nov 2;8(12):bvae192. doi: 10.1210/jendso/bvae192. eCollection 2024 Oct 29. J Endocr Soc. 2024. PMID: 39574788 Free PMC article.
-
Longitudinal Association between Uric Acid and Incident Sarcopenia.Nutrients. 2023 Jul 11;15(14):3097. doi: 10.3390/nu15143097. Nutrients. 2023. PMID: 37513515 Free PMC article.
References
-
- De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010;376:911–921. doi: 10.1016/S0140-6736(10)60355-8 - DOI
-
- Webber L, Davies M, Anderson R, et al. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016;31:926–937. doi: 10.1093/humrep/dew027 - DOI
-
- Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric 2015;18:483–491. doi: 10.3109/13697137.2015.1020484 - DOI
-
- Podfigurna-Stopa A, Czyzyk A, Grymowicz M, et al. Premature ovarian insufficiency: the context of long-term effects. J Endocrinol Invest 2016;39:983–990. doi: 10.1007/s40618-016-0467-z - DOI
-
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022;29:767–794. doi: 10.1097/GME.0000000000002028 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical